[1]
Pavlović, M. et al. 2024. Targeted therapy with entrectinibin children with NTRK rearrangedmesenchymal neoplasms. Paediatria Croatica. 68, 2 (Jul. 2024), 103–106. DOI:https://doi.org/10.13112/PC.2024.15.